rts logo

IGC Pharma Inc (IGC) up 91.18% since start of the year

IGC Pharma Inc (AMEX: IGC) is 91.18% higher on its value in year-to-date trading and has touched a low of $0.25 and a high of $0.50 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The IGC stock was last observed hovering at around $0.48 in the last trading session, with the day’s gains setting it 0.06%.

Currently trading at $0.54, the stock is 49.03% and 66.43% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 2.82 million and changing 12.50% at the moment leaves the stock 64.42% off its SMA200. IGC registered 60.19% gain for a year compared to 6-month loss of 49.04%. The firm has a 50-day simple moving average (SMA 50) of $27.24 and a 200-day simple moving average (SMA200) of -$3.00.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

The stock witnessed a 53.00% gain in the last 1 month and extending the period to 3 months gives it a 91.18%, and is 33.88% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 19.34% over the week and 13.53% over the month.

IGC Pharma Inc (IGC) has around 61 employees, a market worth around $35.38M and $1.22M in sales. Profit margin for the company is -1163.24%. Distance from 52-week low is 114.11% and 7.12% from its 52-week high. The company has generated returns on investments over the last 12 months (-152.00%).

IGC Pharma Inc quarterly earnings per share for the current quarter are estimated at -$0.04 with sales reaching $190k over the same period.

IGC Pharma Inc (IGC) Top Institutional Holders

24 institutions hold shares in IGC Pharma Inc (IGC), with institutional investors hold 4.66% of the company’s shares. The shares outstanding are 66.06M, and float is at 58.81M with Short Float at 1.44%. Institutions hold 3.71% of the Float.

The top institutional shareholder in the company is Blackrock Inc. with over 0.76 million shares valued at $0.24 million. The investor’s holdings represent 1.91% of the IGC Shares outstanding. As of Jun 29, 2023, the second largest holder is Vanguard Group Inc with 0.65 million shares valued at $0.2 million to account for 1.63% of the shares outstanding. The other top investors are Geode Capital Management, LLC which holds 0.3 million shares representing 0.76% and valued at over $94146.0, while State Street Corporation holds 0.47% of the shares totaling 0.18 million with a market value of $57367.0.

Related Posts